Stakeholders ask FDA to harmonize oligonucleotide-based therapeutics guidances

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyGenericsGuidancePharmaceuticalsRegulatory harmonizationRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)